Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Undisclosed
Recipient : Prollergy dba Ready Set Food
Deal Size : Inapplicable
Deal Type : Inapplicable
Early Allergen System Experience
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 16, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Recipient : Prollergy dba Ready Set Food
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Upamostat
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : RedHill Biopharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : This U.S. Phase 2/3 study will examine the safety and efficacy of RedHill Biopharma's RHB-107 (upamostat), using ObvioHealth's clinical trial ecosystem, including digital devices, a patient-centric smartphone application and home healthcare visits.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 03, 2021
Lead Product(s) : Upamostat
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : RedHill Biopharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lumenato
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : LycoRed Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lumenato Nutritional Supplement on Skin Appearance
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 30, 2020
Lead Product(s) : Lumenato
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : LycoRed Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Phytoestrogen
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Recipient : i-Health, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
A Clinical Study Assessing Efficacy of an Herbal Blend on Menopausal Symptoms and Quality of Life
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 14, 2020
Lead Product(s) : Phytoestrogen
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Recipient : i-Health, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable